Thalys Medical Technology Group Corporation (SHA:603716)

Market Cap	4.62B +258.7%
Revenue (ttm)	1.25B -34.2%
Net Income	-240.46M
EPS	-1.26
Shares Out	206.22M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	7,482,946
Average Volume	32,535,766
Open	22.42
Previous Close	22.38
Day's Range	22.22 - 22.65
52-Week Range	7.33 - 38.12
Beta	0.84
RSI	41.91
Earnings Date	Apr 29, 2026

About SHA:603716

Thalys Medical Technology Group Corporation provides medical integrated operation and management services in China. It offers automated immunofluorescence analyzer; coagulation reagent; COVID-19 test kit; line blot1 fully automated immunoblotting instrument; and flow products. The company also provides automated coagulation analyzer; automated immunoassay system; automated biochemical analysis system; automated chemiluminescence immunoassay system; and blood analyzer. The company was formerly known as Thalys Medical Technology Inc. and changed ...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 2004
• Employees: 1,246
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603716

Financial Performance

In 2024, SHA:603716's revenue was 1.81 billion, a decrease of -9.74% compared to the previous year's 2.01 billion. Losses were -209.24 million, 32.0% more than in 2023.